Recently by Joseph H. Tipograph
Health Care Policy Reform Agenda Puts "Reverse Payment" Agreements Between Branded And Generic Drug Makers In The Spotlight: Proposals To Ban Payments Gaining Momentum
This article addresses recent and upcoming developments regarding "reverse payment" pharmaceutical settlements, including: an unresolved circuit split, harmonization of Department of Justice ("DOJ") and Federal Trade Commission ("FTC") antitrust approaches, and a flurry of pending legislation....Read More
Glass-Steagall - A Phoenix About To Rise Again?
In the wake of the current credit crisis and continuing decline in the United States economy, Congress and the Obama administration are expected to introduce sweeping new reforms that will increase governmental oversight of the financial services market. Through reporting requirements and other...Read More